CSL Vifor is a global specialty pharmaceuticals company in the treatment areas of iron deficiency, dialysis, nephrology & rare disease. It is headquartered in Switzerland and consists of CSL Vifor, Vifor Fresenius Medical Care Renal Pharma and Sanifit Therapeutics. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Vifor Pharma (Germany), Germany, covering academic research published from 2000 to 2023. Read More.
Open Access Percentage
54%
Total
Publications
70
Total Open
Publications
38
Total
Citations
1.7K
Open Access
Percentage
54%
Total
Publications
70
Total Open
Publications
38
Total
Citations
1.7K
Breakdown
Publisher Open
33%
Both
18%
Other Platform Open
3%
Closed
46%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 22%
8
Hybrid 39%
14
No Guarantees 39%
14
Other Platform Open
Domain 87%
13
Institution 27%
4
Public 27%
4
Preprint 7%
1
Other Internet 7%
1
Other Platform Locations
Name | Platform Type | Publications |
---|---|---|
PubMed Central | Domain | 13 |
Europe PMC | Domain | 8 |
Semantic Scholar | Public | 4 |
Goethe University Frankfurt - Publication Server of Goethe University Frankfurt am Main | Institution | 2 |
University of Zurich - Zurich Open Repository and Archive | Institution | 1 |
University of Groningen / Centre for Information Technology - University of Groningen research database | Institution | 1 |
Taylor and Francis Group - Dove Medical Press | Other Internet | 1 |
Research Square | Preprint | 1 |
DANS - Data Archiving and Networked Services - NARCIS - National Academic Research and Collaborations Information System | Institution | 1 |